DARIDOREXANT

DARIDOREXANT was reported 2777 times

DARIDOREXANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BILE ACIDS 8 0.8889
1 HYPOKINETIC DYSARTHRIA 23 0.7667
2 TARDIVE SEIZURE 8 0.5714
3 CLENCHED HAND 8 0.4444
4 SMEAR CERVIX 8 0.3810
5 TURBINOPLASTY 8 0.2963
6 BIOPSY TONGUE 8 0.2667
7 SECONDARY TIC 8 0.1951
8 ORAL HAIRY LEUKOPLAKIA 8 0.1600
9 BIOPSY CERVIX 8 0.1538
10 FEAR OF WEIGHT GAIN 8 0.1379
11 CLAUDICATION OF JAW MUSCLES 8 0.1333
12 NEONATAL HEPATOMEGALY 7 0.1250
13 SOMATIC SYMPTOM DISORDER OF PREGNANCY 8 0.1143
14 AVOIDANT PERSONALITY DISORDER 6 0.1111
15 TONGUE ROUGH 8 0.0941
16 NEONATAL HYPOCALCAEMIA 7 0.0933
17 CATATHRENIA 1 0.0769
18 PARADOXICAL INSOMNIA 1 0.0714
19 LEUKOPLAKIA 15 0.0612
20 SLEEP PARALYSIS 64 0.0436
21 APHANTASIA 2 0.0377
22 JAW CLICKING 8 0.0376
23 LACK OF CONCOMITANT DRUG EFFECT 2 0.0351
24 TONGUE GEOGRAPHIC 8 0.0316
25 OROMANDIBULAR DYSTONIA 23 0.0316
26 EXPLODING HEAD SYNDROME 1 0.0312
27 NEONATAL BEHAVIOURAL SYNDROME 9 0.0294
28 NEONATAL HYPERGLYCAEMIA 1 0.0270
29 DYSPRAXIA 15 0.0266
30 CHANGE IN SUSTAINED ATTENTION 8 0.0266
31 FOETAL MACROSOMIA 7 0.0252
32 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 10 0.0234
33 ENCHONDROMATOSIS 2 0.0233
34 BRONCHITIS HAEMOPHILUS 1 0.0227
35 NASAL SEPTAL OPERATION 8 0.0221
36 ANTICIPATORY ANXIETY 6 0.0221
37 LID SULCUS DEEPENED 8 0.0214
38 LUMBAR PUNCTURE 8 0.0211
39 SLEEP INERTIA 2 0.0206
40 LARYNGEAL ERYTHEMA 1 0.0204
41 TRICHOGLOSSIA 8 0.0195
42 LABELLED DRUG-FOOD INTERACTION ISSUE 3 0.0176
43 POSITIVE AIRWAY PRESSURE THERAPY 5 0.0171
44 PLICATED TONGUE 8 0.0168
45 TONGUE ERUPTION 8 0.0161
46 BURNING FEET SYNDROME 4 0.0159
47 LEUKOPLAKIA ORAL 8 0.0156
48 BRONCHOMALACIA 2 0.0152
49 INFANTILE DIARRHOEA 1 0.0152
50 BRAIN COMPRESSION 6 0.0150
51 AMBLYOPIA 8 0.0135
52 INTERVENTIONAL PROCEDURE 1 0.0135
53 HYPERVIGILANCE 13 0.0134
54 HYPNAGOGIC HALLUCINATION 4 0.0131
55 HANGOVER 46 0.0131
56 RENAL FUSION ANOMALY 2 0.0127
57 HYPERAROUSAL 1 0.0116
58 PARASOMNIA 8 0.0111
59 ENDOMETRIAL THICKENING 6 0.0108
60 MENTAL DISABILITY 6 0.0104
61 OVERGROWTH FUNGAL 1 0.0097
62 NEONATAL RESPIRATORY DISTRESS 9 0.0095
63 TONGUE PRURITUS 8 0.0093
64 PRODUCT PACKAGING DIFFICULT TO OPEN 24 0.0092
65 NEUROMUSCULAR BLOCKADE 2 0.0089
66 ILLICIT PRESCRIPTION ATTAINMENT 1 0.0083
67 NIGHTMARE 281 0.0081
68 HYPNOPOMPIC HALLUCINATION 1 0.0081
69 MOANING 9 0.0079
70 LOSS OF DREAMING 1 0.0075
71 GENITAL DISORDER 1 0.0075
72 VULVOVAGINAL CANDIDIASIS 10 0.0074
73 BONE FISSURE 3 0.0072
74 DIAPHRAGMATIC SPASM 1 0.0068
75 PHOBIA OF DRIVING 1 0.0067
76 ANTEROGRADE AMNESIA 4 0.0067
77 BONE LESION EXCISION 1 0.0066
78 NEONATAL RESPIRATORY ACIDOSIS 1 0.0066
79 HYDROCELE 7 0.0066
80 FIBROMA 6 0.0065
81 PRODUCT AVAILABILITY ISSUE 148 0.0065
82 GLOSSITIS 23 0.0065
83 INCREASED DOSE ADMINISTERED 2 0.0064
84 SLEEP-RELATED EATING DISORDER 6 0.0064
85 INTRUSIVE THOUGHTS 7 0.0059
86 SLEEP TERROR 25 0.0059
87 THERAPEUTIC PRODUCT EFFECT VARIABLE 23 0.0059
88 TONGUE DRY 8 0.0059
89 HYPOTONIA NEONATAL 9 0.0058
90 ABNORMAL MENSTRUAL CLOTS 1 0.0057
91 THERAPEUTIC PRODUCT EFFECT DELAYED 26 0.0057
92 CATAPLEXY 8 0.0056
93 AUTOSCOPY 3 0.0056
94 CLAUSTROPHOBIA 6 0.0055
95 SOMNAMBULISM 36 0.0055
96 PERIODIC LIMB MOVEMENT DISORDER 2 0.0054
97 PNEUMONIA KLEBSIELLA 10 0.0054
98 BLOOD KETONE BODY PRESENT 1 0.0053
99 ORGANIC BRAIN SYNDROME 1 0.0053
100 ORAL MUCOSAL EXFOLIATION 8 0.0053
101 POLYCYSTIC OVARIES 8 0.0052
102 TRACHEOMALACIA 2 0.0051
103 ABNORMAL DREAMS 137 0.0050
104 WHITE MATTER LESION 6 0.0047
105 RAPID EYE MOVEMENTS SLEEP ABNORMAL 2 0.0047
106 TONGUE COATED 8 0.0046
107 LARGE FOR DATES BABY 4 0.0045
108 AGORAPHOBIA 6 0.0044
109 CONCOMITANT DISEASE AGGRAVATED 27 0.0044
110 DISTURBANCE IN SEXUAL AROUSAL 4 0.0043
111 NEONATAL PNEUMONIA 1 0.0043
112 NASAL INJURY 3 0.0042
113 PNEUMOTHORAX TRAUMATIC 1 0.0041
114 SLEEP TALKING 7 0.0041
115 ACCIDENT AT HOME 2 0.0039
116 PRODUCT KNOWLEDGE DEFICIT 3 0.0038
117 ABNORMAL SLEEP-RELATED EVENT 5 0.0038
118 GRIEF REACTION 2 0.0038
119 PERIPHERAL PARALYSIS 1 0.0037
120 EYELID THICKENING 1 0.0035
121 FLASHBACK 2 0.0035
122 EAR INFLAMMATION 1 0.0035
123 SCHIZOAFFECTIVE DISORDER 6 0.0034
124 UTERINE POLYP 6 0.0033
125 MENOMETRORRHAGIA 6 0.0031
126 VAGINAL DISORDER 3 0.0031
127 MENOPAUSE 8 0.0031
128 NASAL CRUSTING 2 0.0031
129 POISONING DELIBERATE 29 0.0031
130 MIDDLE INSOMNIA 57 0.0030
131 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
132 CENTRAL NERVOUS SYSTEM INFLAMMATION 1 0.0030
133 BACTERIAL PYELONEPHRITIS 1 0.0030
134 NON-ALCOHOLIC FATTY LIVER 1 0.0030
135 BRAIN FOG 45 0.0029
136 MUSCLE HYPERTROPHY 1 0.0028
137 HEMIHYPOAESTHESIA 1 0.0028
138 MIXED ANXIETY AND DEPRESSIVE DISORDER 1 0.0027
139 NASAL TURBINATE HYPERTROPHY 1 0.0027
140 TACHYPHRENIA 9 0.0026
141 BLOOD PROLACTIN INCREASED 12 0.0025
142 LEARNING DISORDER 6 0.0025
143 KETONURIA 2 0.0025
144 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
145 PRODUCT CONTAINER SEAL ISSUE 4 0.0023
146 SELF-DESTRUCTIVE BEHAVIOUR 2 0.0023
147 CLEFT LIP 2 0.0023
148 MUSCLE SWELLING 2 0.0022
149 ELECTRIC SHOCK SENSATION 6 0.0021
150 NARCOLEPSY 4 0.0021
151 PRE-ECLAMPSIA 10 0.0021
152 GINGIVAL DISORDER 8 0.0021
153 ANAEMIA NEONATAL 1 0.0021
154 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
155 HYPOCOAGULABLE STATE 2 0.0021
156 ECZEMA NUMMULAR 1 0.0020
157 MYASTHENIA GRAVIS CRISIS 3 0.0020
158 HYPOHIDROSIS 1 0.0020
159 PERIPHERAL ISCHAEMIA 8 0.0020
160 HICCUPS 16 0.0019
161 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
162 INITIAL INSOMNIA 19 0.0018
163 HYPERTROPHY 1 0.0018
164 CONJUNCTIVAL HAEMORRHAGE 7 0.0018
165 TONGUE DISCOLOURATION 8 0.0018
166 POOR QUALITY SLEEP 39 0.0018
167 MYOCARDIAL INJURY 2 0.0018
168 HYPERBILIRUBINAEMIA NEONATAL 1 0.0017
169 DEPRESSIVE SYMPTOM 6 0.0017
170 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
171 TERMINAL INSOMNIA 3 0.0017
172 HEPATITIS FULMINANT 5 0.0017
173 CHEILITIS 9 0.0017
174 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7 0.0017
175 ELBOW OPERATION 1 0.0016
176 ARTHRITIS REACTIVE 1 0.0016
177 SCREAMING 10 0.0016
178 DISSOCIATION 12 0.0016
179 TRISMUS 8 0.0015
180 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 3 0.0015
181 DEFAECATION DISORDER 1 0.0015
182 BRUXISM 8 0.0015
183 FEELING OF RELAXATION 1 0.0015
184 PAINFUL ERECTION 1 0.0015
185 BORDERLINE PERSONALITY DISORDER 1 0.0014
186 SKIN WEEPING 5 0.0014
187 THROMBOCYTOSIS 5 0.0014
188 MENTAL FATIGUE 2 0.0013
189 LOSS OF EMPLOYMENT 4 0.0013
190 MARASMUS 2 0.0013
191 CREATINE KINASE INCREASED 1 0.0013
192 DRUG TOLERANCE INCREASED 1 0.0013
193 MUSCLE DISCOMFORT 1 0.0013
194 EOSINOPHIL COUNT DECREASED 3 0.0013
195 PARALYSIS 18 0.0013
196 NASAL ULCER 2 0.0013
197 INTERMENSTRUAL BLEEDING 7 0.0013
198 DISINHIBITION 2 0.0012
199 EXCESSIVE GRANULATION TISSUE 1 0.0012
200 INSOMNIA 327 0.0012
201 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
202 ESCHERICHIA INFECTION 10 0.0012
203 NEAR DEATH EXPERIENCE 4 0.0012
204 FOETAL DISORDER 1 0.0012
205 ANXIETY DISORDER 4 0.0012
206 ENERGY INCREASED 7 0.0012
207 SEIZURE LIKE PHENOMENA 2 0.0012
208 SEDATION COMPLICATION 3 0.0012
209 DEAFNESS TRANSITORY 1 0.0012
210 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 83 0.0012
211 ATONIC SEIZURES 1 0.0012
212 ENDOCRINE OPHTHALMOPATHY 1 0.0012
213 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
214 APHONIA 16 0.0011
215 IMPAIRED DRIVING ABILITY 13 0.0011
216 SKIN HYPOPIGMENTATION 2 0.0011
217 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 1 0.0011
218 INTENTIONAL OVERDOSE 71 0.0011
219 TONGUE DISORDER 8 0.0011
220 CERUMEN IMPACTION 1 0.0011
221 SUICIDAL IDEATION 100 0.0011
222 SLUGGISHNESS 11 0.0011
223 HALLUCINATION 81 0.0011
224 BRADYPHRENIA 7 0.0011
225 NOCTURIA 13 0.0011
226 BUNDLE BRANCH BLOCK 1 0.0011
227 FACIAL ASYMMETRY 1 0.0010
228 RESTLESS LEGS SYNDROME 19 0.0010
229 CONVERSION DISORDER 2 0.0010
230 NEGATIVE THOUGHTS 3 0.0010
231 MASTOIDITIS 1 0.0010
232 JOINT NOISE 2 0.0010
233 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
234 GINGIVAL PAIN 8 0.0010
235 ANTISOCIAL BEHAVIOUR 1 0.0010
236 HEPATITIS CHOLESTATIC 6 0.0010
237 CARDIAC DISCOMFORT 2 0.0010
238 DILATED CARDIOMYOPATHY 1 0.0010
239 HYPERPARATHYROIDISM 2 0.0010
240 BREAST DISCOMFORT 1 0.0010
241 SOCIAL PROBLEM 4 0.0010
242 HEMIPLEGIA 8 0.0010
243 PERTUSSIS 1 0.0010
244 LIVEDO RETICULARIS 2 0.0010
245 RESTLESSNESS 35 0.0010
246 FOREIGN BODY IN THROAT 3 0.0010
247 GALACTORRHOEA 6 0.0009
248 VULVOVAGINAL DRYNESS 3 0.0009
249 BINGE EATING 1 0.0009
250 LANGUAGE DISORDER 2 0.0009
251 SOMNOLENCE 183 0.0009
252 DYSARTHRIA 34 0.0009
253 NIGHT SWEATS 29 0.0009
254 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
255 TARDIVE DYSKINESIA 25 0.0009
256 LIP DRY 8 0.0009
257 DYSLEXIA 1 0.0009
258 FLAT AFFECT 2 0.0009
259 HYPERTRIGLYCERIDAEMIA 5 0.0009
260 HYPERTENSIVE EMERGENCY 1 0.0008
261 THERAPEUTIC PRODUCT EFFECT DECREASED 38 0.0008
262 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
263 URINARY HESITATION 2 0.0008
264 OTITIS EXTERNA 1 0.0008
265 SUFFOCATION FEELING 2 0.0008
266 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
267 SNORING 3 0.0008
268 MANIA 13 0.0008
269 HYPERTHERMIA 6 0.0008
270 ANGLE CLOSURE GLAUCOMA 2 0.0008
271 CHOLESTASIS 15 0.0008
272 PHYSICAL DECONDITIONING 2 0.0008
273 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 37 0.0008
274 JOINT DISLOCATION 8 0.0008
275 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
276 LIP EXFOLIATION 1 0.0008
277 SENSORY LOSS 6 0.0007
278 ENURESIS 3 0.0007
279 BODY MASS INDEX INCREASED 1 0.0007
280 MIGRAINE WITH AURA 2 0.0007
281 PRODUCT PRESCRIBING ISSUE 16 0.0007
282 HYPERSOMNIA 21 0.0007
283 BEZOAR 1 0.0007
284 DRUG SCREEN FALSE POSITIVE 2 0.0007
285 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
286 SELF-INJURIOUS IDEATION 3 0.0007
287 HEPATIC CYTOLYSIS 9 0.0007
288 DISTURBANCE IN ATTENTION 38 0.0007
289 INTERVERTEBRAL DISC DISORDER 3 0.0007
290 NONINFECTIVE GINGIVITIS 1 0.0007
291 DYSPNOEA AT REST 2 0.0007
292 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
293 ORAL CANDIDIASIS 9 0.0007
294 FEELING JITTERY 13 0.0007
295 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 122 0.0007
296 HYPERTHERMIA MALIGNANT 1 0.0007
297 COMA 32 0.0007
298 MIXED LIVER INJURY 2 0.0007
299 HALLUCINATION, VISUAL 14 0.0007
300 ORAL MUCOSAL ERUPTION 1 0.0007
301 DAYDREAMING 1 0.0006
302 TALIPES 2 0.0006
303 HYPERCHOLESTEROLAEMIA 6 0.0006
304 FIBROMYALGIA 15 0.0006
305 HAND DEFORMITY 8 0.0006
306 PAPILLOMA VIRAL INFECTION 1 0.0006
307 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
308 AGITATION 44 0.0006
309 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
310 DRUG USE DISORDER 5 0.0006
311 AKATHISIA 8 0.0006
312 GLIOBLASTOMA 1 0.0006
313 LAZINESS 1 0.0006
314 PERIPHERAL COLDNESS 8 0.0006
315 DEPRESSION SUICIDAL 2 0.0006
316 FORMICATION 4 0.0006
317 SEROTONIN SYNDROME 11 0.0006
318 EMOTIONAL POVERTY 1 0.0006
319 CARDIOMEGALY 7 0.0006
320 LOGORRHOEA 2 0.0006
321 BREAST CYST 1 0.0006
322 MUSCLE TWITCHING 13 0.0006
323 OBSESSIVE THOUGHTS 1 0.0006
324 DEPRESSED MOOD 29 0.0005
325 HYPERSEXUALITY 1 0.0005
326 SUICIDE ATTEMPT 33 0.0005
327 HYPOMANIA 2 0.0005
328 DISORGANISED SPEECH 1 0.0005
329 FEELING DRUNK 4 0.0005
330 BLADDER SPASM 1 0.0005
331 BONE LOSS 8 0.0005
332 INFECTED SKIN ULCER 1 0.0005
333 LIP DISORDER 1 0.0005
334 GUN SHOT WOUND 1 0.0005
335 FEELING ABNORMAL 124 0.0005
336 CONCUSSION 4 0.0005
337 PRODUCT LABEL CONFUSION 3 0.0005
338 CONCOMITANT DISEASE PROGRESSION 1 0.0005
339 NASAL SEPTUM DEVIATION 1 0.0005
340 AFFECTIVE DISORDER 4 0.0005
341 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
342 DIPLEGIA 1 0.0005
343 EMPYEMA 1 0.0005
344 HYPERPHAGIA 2 0.0005
345 GASTROENTERITIS VIRAL 9 0.0005
346 RHINITIS 4 0.0005
347 VAGINAL DISCHARGE 5 0.0005
348 VITAMIN B12 DEFICIENCY 2 0.0005
349 PANIC ATTACK 18 0.0005
350 MUSCLE CONTRACTURE 1 0.0005
351 EAR DISCOMFORT 5 0.0005
352 POLYCYTHAEMIA 1 0.0005
353 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
354 ANAL PRURITUS 1 0.0005
355 BODY TEMPERATURE FLUCTUATION 1 0.0005
356 SKIN PLAQUE 4 0.0005
357 ANGER 16 0.0005
358 HAEMOGLOBIN ABNORMAL 3 0.0005
359 TENSION HEADACHE 2 0.0005
360 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
361 PARANOIA 8 0.0005
362 APHASIA 14 0.0005
363 JAW FRACTURE 1 0.0005
364 SEDATION 12 0.0005
365 EOSINOPHILIA 8 0.0005
366 CEREBELLAR SYNDROME 1 0.0005
367 BIPOLAR I DISORDER 1 0.0005
368 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
369 MIDDLE EAR EFFUSION 1 0.0005
370 LIGAMENT RUPTURE 2 0.0005
371 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 91 0.0004
372 MENINGIOMA 7 0.0004
373 DRY MOUTH 36 0.0004
374 HALLUCINATION, AUDITORY 7 0.0004
375 DYSPAREUNIA 2 0.0004
376 COORDINATION ABNORMAL 6 0.0004
377 THINKING ABNORMAL 8 0.0004
378 PATELLA FRACTURE 1 0.0004
379 PALPITATIONS 50 0.0004
380 ESCHERICHIA BACTERAEMIA 1 0.0004
381 LEUKAEMIA 4 0.0004
382 PRODUCT PRESCRIBING ERROR 10 0.0004
383 LACUNAR INFARCTION 1 0.0004
384 HEMIPARESIS 7 0.0004
385 CIRCULATORY COLLAPSE 7 0.0004
386 INTENTIONAL UNDERDOSE 3 0.0004
387 MAJOR DEPRESSION 3 0.0004
388 HAEMATOLOGICAL INFECTION 1 0.0004
389 SCAR 7 0.0004
390 MIGRAINE 39 0.0004
391 RESPIRATORY DEPRESSION 5 0.0004
392 LIVER INJURY 10 0.0004
393 ABDOMINAL TENDERNESS 2 0.0004
394 BRAIN INJURY 4 0.0004
395 ILLNESS 41 0.0004
396 INTENTIONAL SELF-INJURY 8 0.0004
397 DYSPHORIA 2 0.0004
398 DYSPHONIA 23 0.0004
399 DYSPHAGIA 37 0.0004
400 TEMPERATURE INTOLERANCE 4 0.0004
401 DRUG TITRATION ERROR 1 0.0004
402 VARICOSE VEIN 2 0.0004
403 APNOEA 3 0.0004
404 LETHARGY 22 0.0004
405 CATATONIA 2 0.0004
406 NYSTAGMUS 2 0.0004
407 MOOD SWINGS 12 0.0004
408 ALCOHOL POISONING 1 0.0004
409 HYPERLACTACIDAEMIA 1 0.0004
410 LARYNGOSPASM 1 0.0004
411 BRADYPNOEA 1 0.0004
412 IMPAIRED GASTRIC EMPTYING 5 0.0004
413 CLUMSINESS 1 0.0004
414 DRUG INEFFECTIVE 482 0.0004
415 PREMATURE BABY 11 0.0004
416 SEIZURE 42 0.0004
417 CHOKING SENSATION 2 0.0004
418 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
419 URINARY RETENTION 12 0.0004
420 GLOSSODYNIA 8 0.0004
421 SWOLLEN TONGUE 11 0.0004
422 FACIAL PARALYSIS 3 0.0004
423 PARAPLEGIA 1 0.0003
424 COMA SCALE ABNORMAL 1 0.0003
425 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
426 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
427 DRUG INTERACTION 54 0.0003
428 HEAD DISCOMFORT 6 0.0003
429 PLEURISY 2 0.0003
430 POLLAKIURIA 14 0.0003
431 MYOCLONUS 4 0.0003
432 MENTAL IMPAIRMENT 8 0.0003
433 NEURALGIA 8 0.0003
434 TENSION 2 0.0003
435 MASTICATION DISORDER 1 0.0003
436 LIMB DISCOMFORT 10 0.0003
437 PRODUCT DISPENSING ERROR 7 0.0003
438 DYSKINESIA 13 0.0003
439 DEPRESSION 72 0.0003
440 PHOTOPSIA 2 0.0003
441 HEAD INJURY 10 0.0003
442 PRODUCT PACKAGING ISSUE 3 0.0003
443 FOREIGN BODY SENSATION IN EYES 2 0.0003
444 HYPERPROLACTINAEMIA 2 0.0003
445 HEPATITIS ACUTE 2 0.0003
446 LYMPHOCYTE COUNT INCREASED 1 0.0003
447 DEAFNESS NEUROSENSORY 1 0.0003
448 CRYING 11 0.0003
449 LYME DISEASE 1 0.0003
450 IRRITABILITY 18 0.0003
451 POST-TRAUMATIC STRESS DISORDER 2 0.0003
452 PLANTAR FASCIITIS 1 0.0003
453 POTENTIATING DRUG INTERACTION 1 0.0003
454 FEAR 8 0.0003
455 TREMOR 49 0.0003
456 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
457 MICTURITION DISORDER 1 0.0003
458 SLEEP DISORDER 20 0.0003
459 TINNITUS 13 0.0003
460 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
461 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
462 EATING DISORDER 6 0.0003
463 DEVICE PLACEMENT ISSUE 1 0.0003
464 PARAESTHESIA ORAL 4 0.0003
465 PANIC REACTION 2 0.0003
466 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
467 LEUKOCYTOSIS 5 0.0003
468 BLOOD PHOSPHORUS DECREASED 1 0.0003
469 MUSCULAR WEAKNESS 31 0.0003
470 PARADOXICAL DRUG REACTION 1 0.0003
471 DYSURIA 10 0.0003
472 FREEZING PHENOMENON 1 0.0003
473 ARTHROPOD BITE 2 0.0003
474 HEADACHE 168 0.0003
475 NERVOUSNESS 14 0.0003
476 EYE PRURITUS 9 0.0003
477 THROAT IRRITATION 12 0.0003
478 MICTURITION URGENCY 3 0.0003
479 VERTIGO 16 0.0003
480 SLEEP APNOEA SYNDROME 5 0.0003
481 INCREASED APPETITE 5 0.0003
482 CLAVICLE FRACTURE 1 0.0003
483 ANXIETY 74 0.0003
484 DELIRIUM 9 0.0003
485 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
486 CARDIOPULMONARY FAILURE 1 0.0003
487 ORAL INFECTION 1 0.0003
488 SEXUAL DYSFUNCTION 3 0.0003
489 BONE DENSITY DECREASED 8 0.0003
490 MULTIPLE ALLERGIES 2 0.0003
491 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
492 DISABILITY 5 0.0003
493 DISORIENTATION 10 0.0003
494 NASAL DISCOMFORT 2 0.0003
495 PATENT DUCTUS ARTERIOSUS 1 0.0003
496 EXPOSURE VIA BREAST MILK 1 0.0003
497 PRODUCT PHYSICAL ISSUE 5 0.0002
498 FRUSTRATION TOLERANCE DECREASED 2 0.0002
499 GALLBLADDER OPERATION 1 0.0002
500 DISCOMFORT 15 0.0002
501 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
502 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
503 NO ADVERSE EVENT 44 0.0002
504 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
505 HYPERSENSITIVITY 45 0.0002
506 GENERALISED OEDEMA 3 0.0002
507 HALLUCINATIONS, MIXED 1 0.0002
508 HEPATIC PAIN 1 0.0002
509 PYELONEPHRITIS 2 0.0002
510 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
511 DYSPHEMIA 1 0.0002
512 GRIP STRENGTH DECREASED 2 0.0002
513 ABORTION SPONTANEOUS 9 0.0002
514 NERVOUS SYSTEM DISORDER 7 0.0002
515 ISCHAEMIC STROKE 4 0.0002
516 ILEUS PARALYTIC 1 0.0002
517 MALIGNANT MELANOMA 3 0.0002
518 BRAIN NEOPLASM MALIGNANT 1 0.0002
519 PRODUCT TASTE ABNORMAL 3 0.0002
520 PAPILLOEDEMA 1 0.0002
521 DRY EYE 11 0.0002
522 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
523 MOOD ALTERED 6 0.0002
524 FATIGUE 171 0.0002
525 SKIN LESION 6 0.0002
526 EAR DISORDER 1 0.0002
527 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
528 RESPIRATORY DISTRESS 6 0.0002
529 INCREASED TENDENCY TO BRUISE 2 0.0002
530 PROCEDURAL PAIN 6 0.0002
531 LOCALISED OEDEMA 1 0.0002
532 COMPLETED SUICIDE 18 0.0002
533 HUNGER 3 0.0002
534 PERFORMANCE STATUS DECREASED 1 0.0002
535 COLITIS MICROSCOPIC 1 0.0002
536 INTENTIONAL DOSE OMISSION 6 0.0002
537 BRONCHOSPASM 3 0.0002
538 HYPERHIDROSIS 27 0.0002
539 SUBDURAL HAEMATOMA 3 0.0002
540 NON-SMALL CELL LUNG CANCER 1 0.0002
541 LIMB OPERATION 1 0.0002
542 PRESCRIBED OVERDOSE 4 0.0002
543 INCORRECT DOSAGE ADMINISTERED 1 0.0002
544 KNEE OPERATION 2 0.0002
545 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
546 ORGANISING PNEUMONIA 1 0.0002
547 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
548 PULMONARY MASS 3 0.0002
549 DERMATITIS EXFOLIATIVE 1 0.0002
550 LYMPHADENOPATHY 7 0.0002
551 MEMORY IMPAIRMENT 27 0.0002
552 DIZZINESS 98 0.0002
553 EUPHORIC MOOD 2 0.0002
554 FEMORAL NECK FRACTURE 1 0.0002
555 EYE PAIN 11 0.0002
556 TENDONITIS 3 0.0002
557 DIPLOPIA 5 0.0002
558 EYE DISCHARGE 2 0.0002
559 RHABDOMYOLYSIS 8 0.0002
560 ACCIDENTAL OVERDOSE 7 0.0002
561 SPEECH DISORDER 10 0.0002
562 PRODUCT USE COMPLAINT 3 0.0002
563 FOOD CRAVING 1 0.0002
564 SCIATICA 3 0.0002
565 ANAL FISTULA 1 0.0002
566 IMPAIRED WORK ABILITY 4 0.0002
567 OVERWEIGHT 1 0.0002
568 JAUNDICE 5 0.0002
569 MUSCLE SPASMS 34 0.0002
570 BEHAVIOUR DISORDER 1 0.0002
571 PHARYNGITIS STREPTOCOCCAL 2 0.0002
572 AMNESIA 12 0.0002
573 FAECALOMA 1 0.0002
574 ASTHENOPIA 1 0.0002
575 HEART RATE INCREASED 18 0.0002
576 STOMATITIS 11 0.0002
577 FEELING COLD 5 0.0002
578 INTRACRANIAL PRESSURE INCREASED 1 0.0002
579 HEART RATE ABNORMAL 1 0.0002
580 CHILLS 21 0.0002
581 DEMENTIA 5 0.0002
582 OCULAR DISCOMFORT 2 0.0002
583 EYE INFECTION 2 0.0002
584 HEART RATE IRREGULAR 4 0.0002
585 PERIORBITAL SWELLING 1 0.0002
586 PERONEAL NERVE PALSY 1 0.0002
587 INTERNAL HAEMORRHAGE 2 0.0002
588 NEUROLOGICAL SYMPTOM 1 0.0002
589 EXERCISE TOLERANCE DECREASED 1 0.0002
590 HYPOAESTHESIA 26 0.0002
591 CONFUSIONAL STATE 28 0.0002
592 HYPERVENTILATION 1 0.0002
593 ELECTROLYTE IMBALANCE 2 0.0002
594 AMENORRHOEA 3 0.0002
595 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
596 DECREASED INTEREST 1 0.0002
597 BRADYKINESIA 1 0.0002
598 ATAXIA 2 0.0002
599 MUSCLE RIGIDITY 2 0.0002
600 LACRIMATION INCREASED 5 0.0002
601 INJECTION SITE VESICLES 1 0.0002
602 MYALGIA 28 0.0002
603 PRESYNCOPE 4 0.0002
604 INGUINAL HERNIA 1 0.0002
605 SPINAL OPERATION 2 0.0002
606 ILEUS 2 0.0002
607 HOT FLUSH 12 0.0002
608 MULTIPLE INJURIES 1 0.0002
609 ERECTILE DYSFUNCTION 4 0.0002
610 ABDOMINAL DISCOMFORT 26 0.0002
611 CARDIAC FLUTTER 1 0.0002
612 VISION BLURRED 21 0.0002
613 POLYP 1 0.0002
614 HYPOGAMMAGLOBULINAEMIA 1 0.0002
615 CORONAVIRUS INFECTION 1 0.0002
616 APPETITE DISORDER 1 0.0002
617 UPPER LIMB FRACTURE 3 0.0002
618 BALANCE DISORDER 13 0.0002
619 PRESCRIBED UNDERDOSE 3 0.0002
620 LIP SWELLING 5 0.0001
621 JOINT RANGE OF MOTION DECREASED 2 0.0001
622 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
623 FEEDING DISORDER 3 0.0001
624 THROAT TIGHTNESS 4 0.0001
625 EYE MOVEMENT DISORDER 1 0.0001
626 RIB FRACTURE 3 0.0001
627 DROOLING 1 0.0001
628 LARGE INTESTINE POLYP 1 0.0001
629 MEDICATION ERROR 8 0.0001
630 HAND FRACTURE 1 0.0001
631 HEPATOCELLULAR INJURY 2 0.0001
632 SYNCOPE 14 0.0001
633 IRRITABLE BOWEL SYNDROME 3 0.0001
634 PARAESTHESIA 22 0.0001
635 ANGINA PECTORIS 4 0.0001
636 IMPAIRED QUALITY OF LIFE 2 0.0001
637 WEIGHT INCREASED 31 0.0001
638 APATHY 2 0.0001
639 INTENTIONAL PRODUCT MISUSE 12 0.0001
640 CARDIOMYOPATHY 2 0.0001
641 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
642 HYPOPHOSPHATAEMIA 1 0.0001
643 TACHYCARDIA 12 0.0001
644 HEPATIC FUNCTION ABNORMAL 5 0.0001
645 KETOACIDOSIS 1 0.0001
646 HYPOAESTHESIA ORAL 2 0.0001
647 PAROSMIA 1 0.0001
648 ACIDOSIS 1 0.0001
649 NEPHROLITHIASIS 6 0.0001
650 HAEMOLYSIS 1 0.0001
651 MUSCULOSKELETAL CHEST PAIN 2 0.0001
652 MALAISE 56 0.0001
653 CHEST DISCOMFORT 13 0.0001
654 ABDOMINAL PAIN UPPER 26 0.0001
655 BLOOD ALBUMIN DECREASED 1 0.0001
656 LOW BIRTH WEIGHT BABY 1 0.0001
657 ATRIAL FLUTTER 1 0.0001
658 LOSS OF CONSCIOUSNESS 16 0.0001
659 NAUSEA 98 0.0001
660 MUSCLE DISORDER 1 0.0001
661 MUSCLE TIGHTNESS 2 0.0001
662 POST PROCEDURAL INFECTION 1 0.0001
663 ASPHYXIA 1 0.0001
664 PHOTOSENSITIVITY REACTION 2 0.0001
665 EPISTAXIS 9 0.0001
666 GAIT INABILITY 4 0.0001
667 ROAD TRAFFIC ACCIDENT 5 0.0001
668 ATRIAL SEPTAL DEFECT 1 0.0001
669 SURGERY 7 0.0001
670 BLOOD PRESSURE INCREASED 18 0.0001
671 FALL 39 0.0001
672 ANURIA 1 0.0001
673 ORTHOSTATIC HYPOTENSION 2 0.0001
674 JOINT STIFFNESS 3 0.0001
675 ANHEDONIA 3 0.0001
676 BLOOD CALCIUM INCREASED 1 0.0001
677 HEART RATE DECREASED 4 0.0001
678 HYPERTENSION 24 0.0001
679 DRY SKIN 15 0.0001
680 THIRST 2 0.0001
681 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
682 ANAL INCONTINENCE 1 0.0001
683 HEAVY MENSTRUAL BLEEDING 1 0.0001
684 SYNOVITIS 2 0.0001
685 OROPHARYNGEAL DISCOMFORT 1 0.0001
686 LIMB INJURY 3 0.0001
687 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
688 NERVE COMPRESSION 1 0.0001
689 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
690 CONJUNCTIVITIS 2 0.0001
691 EYE SWELLING 4 0.0001
692 HEPATIC ENCEPHALOPATHY 1 0.0001
693 COGNITIVE DISORDER 5 0.0001
694 DIARRHOEA HAEMORRHAGIC 1 0.0001
695 PRURITUS 41 0.0001
696 FLANK PAIN 1 0.0001
697 PRODUCT USE ISSUE 20 0.0001
698 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
699 ARRHYTHMIA 5 0.0001
700 ACNE 8 0.0001
701 CONSTIPATION 23 0.0001
702 GAIT DISTURBANCE 20 0.0001
703 POST PROCEDURAL COMPLICATION 2 0.0001
704 AFFECT LABILITY 1 0.0001
705 HERNIA 2 0.0001
706 ERUCTATION 2 0.0001
707 DIZZINESS POSTURAL 1 0.0001
708 DYSTONIA 2 0.0001
709 PRODUCT QUALITY ISSUE 14 0.0001
710 CHEST PAIN 19 0.0001
711 PARKINSONISM 1 0.0001
712 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
713 HAEMORRHOIDS 2 0.0001
714 PHARYNGEAL SWELLING 1 0.0001
715 URINARY INCONTINENCE 3 0.0001
716 BURNING SENSATION 7 0.0001
717 BLOOD POTASSIUM DECREASED 3 0.0001
718 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
719 EYELID PTOSIS 1 0.0001
720 MOTOR DYSFUNCTION 1 0.0001
721 BODY TEMPERATURE INCREASED 2 0.0001
722 FEELING HOT 6 0.0001
723 EMOTIONAL DISORDER 3 0.0001
724 RASH 42 0.0001
725 RESPIRATORY FAILURE 7 0.0001
726 DECREASED APPETITE 22 0.0001
727 PULMONARY EMBOLISM 9 0.0001
728 BREAST PAIN 1 0.0001
729 DRUG INTOLERANCE 9 0.0001
730 MENSTRUATION DELAYED 1 0.0001
731 FAECES DISCOLOURED 2 0.0001
732 VAGINAL HAEMORRHAGE 4 0.0001
733 BACK INJURY 1 0.0001
734 HAEMATOCHEZIA 5 0.0001
735 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
736 FOOT DEFORMITY 1 0.0001
737 LIVER DISORDER 4 0.0001
738 RASH MACULO-PAPULAR 2 0.0001
739 URTICARIA 15 0.0001
740 NECK PAIN 5 0.0001
741 MALNUTRITION 1 0.0001
742 CONDITION AGGRAVATED 27 0.0001
743 CHROMATURIA 2 0.0001
744 FLATULENCE 5 0.0001
745 OVERDOSE 19 0.0001
746 URINARY TRACT INFECTION 15 0.0001
747 DERMATITIS CONTACT 1 0.0001
748 SKIN DISCOLOURATION 4 0.0001
749 ABDOMINAL DISTENSION 9 0.0001
750 CARDIAC DISORDER 8 0.0001
751 ASTHENIA 32 0.0001
752 COVID-19 PNEUMONIA 1 0.0001
753 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
754 ACCIDENT 1 0.0001
755 ATRIAL FIBRILLATION 8 0.0001
756 CYTOPENIA 1 0.0001
757 DYSPNOEA 46 0.0001
758 HYPERCALCAEMIA 1 0.0001
759 PHARYNGITIS 1 0.0001
760 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
761 INJECTION SITE DISCOLOURATION 1 0.0001
762 AGGRESSION 4 0.0001
763 DYSPNOEA EXERTIONAL 3 0.0001
764 INTESTINAL OBSTRUCTION 3 0.0001
765 UNEVALUABLE EVENT 6 0.0001
766 DIARRHOEA 51 0.0001
767 MUSCLE ATROPHY 1 0.0001
768 ACUTE KIDNEY INJURY 12 0.0001
769 INTRAOCULAR PRESSURE INCREASED 1 0.0001
770 SINUSITIS 8 0.0001
771 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
772 UNRESPONSIVE TO STIMULI 2 0.0001
773 HAEMATOMA 2 0.0001
774 INJECTION SITE INDURATION 1 0.0001
775 SWELLING FACE 5 0.0001
776 DEAFNESS 2 0.0001
777 IMMUNE SYSTEM DISORDER 1 0.0001
778 ABNORMAL BEHAVIOUR 3 0.0001
779 ADVERSE REACTION 1 0.0001
780 EAR INFECTION 2 0.0001
781 VOMITING 35 0.0001
782 ACUTE HEPATIC FAILURE 1 0.0001
783 OSTEOPOROSIS 3 0.0001
784 DIVERTICULITIS 2 0.0001
785 DRUG ABUSE 6 0.0001
786 CARPAL TUNNEL SYNDROME 1 0.0001
787 LYMPHOPENIA 1 0.0001
788 RECTAL HAEMORRHAGE 3 0.0001
789 HYPERTHYROIDISM 1 0.0001
790 HYPOKINESIA 1 0.0001
791 BACK PAIN 16 0.0001
792 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
793 GASTROENTERITIS 1 0.0001
794 DYSSTASIA 2 0.0001
795 COVID-19 12 0.0001
796 BONE PAIN 4 0.0001
797 NASAL CONGESTION 4 0.0001
798 PRODUCT DOSE OMISSION ISSUE 20 0.0001
799 PSYCHOTIC DISORDER 2 0.0001
800 DYSGEUSIA 5 0.0001
801 PYREXIA 23 0.0001
802 EMOTIONAL DISTRESS 8 0.0001
803 EPILEPSY 2 0.0001
804 INSURANCE ISSUE 1 0.0001
805 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
806 HYPOKALAEMIA 3 0.0001
807 ANKLE FRACTURE 1 0.0001
808 PAIN IN EXTREMITY 19 0.0001
809 DELUSION 1 0.0001
810 EXPOSURE DURING PREGNANCY 4 0.0001
811 OCULAR HYPERAEMIA 3 0.0001
812 PNEUMOTHORAX 1 0.0001
813 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
814 RHINORRHOEA 4 0.0001
815 IMPAIRED HEALING 2 0.0001
816 BLOOD PRESSURE DECREASED 4 0.0001
817 VIRAL INFECTION 2 0.0001
818 FUNGAL INFECTION 2 0.0001
819 DEHYDRATION 8 0.0001
820 HYPOTENSION 12 0.0001
821 RENAL IMPAIRMENT 5 0.0001
822 TYPE 2 DIABETES MELLITUS 2 0.0001
823 FACE OEDEMA 1 0.0001
824 MUSCULOSKELETAL DISCOMFORT 1 0.0001
825 JOINT SWELLING 7 0.0001
826 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
827 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
828 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
829 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
830 DRUG ERUPTION 1 0.0001
831 GALLBLADDER DISORDER 1 0.0001
832 THERAPY INTERRUPTED 4 0.0001
833 MOBILITY DECREASED 4 0.0001
834 COMPLICATION OF DEVICE REMOVAL 1 0.0001
835 HEPATIC STEATOSIS 1 0.0001
836 COUGH 15 0.0001
837 HYPONATRAEMIA 3 0.0001
838 HEPATIC CIRRHOSIS 1 0.0001
839 PHOTOPHOBIA 1 0.0001
840 ASTHMA 6 0.0001
841 FOOT FRACTURE 1 0.0001
842 GASTRIC ULCER 1 0.0001
843 MUSCULOSKELETAL DISORDER 1 0.0001
844 EYE IRRITATION 3 0.0001
845 GLAUCOMA 1 0.0001
846 ABDOMINAL PAIN 12 0.0001
847 EAR PAIN 1 0.0001
848 CHOKING 1 0.0001
849 ORAL HERPES 1 0.0001
850 KIDNEY INFECTION 1 0.0001
851 DYSPEPSIA 5 0.0001
852 BONE MARROW FAILURE 1 0.0000
853 INFLUENZA LIKE ILLNESS 4 0.0000
854 WITHDRAWAL SYNDROME 2 0.0000
855 KNEE ARTHROPLASTY 1 0.0000
856 MOUTH ULCERATION 1 0.0000
857 JOINT INJURY 1 0.0000
858 LIVER FUNCTION TEST INCREASED 1 0.0000
859 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
860 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
861 MENTAL DISORDER 2 0.0000
862 ALOPECIA 9 0.0000
863 ARTHRALGIA 19 0.0000
864 PAIN 28 0.0000
865 MELAENA 1 0.0000
866 ANGIOEDEMA 2 0.0000
867 INJECTION SITE PRURITUS 3 0.0000
868 HEPATIC ENZYME INCREASED 3 0.0000
869 ERYTHEMA 9 0.0000
870 PNEUMONIA 14 0.0000
871 RENAL DISORDER 2 0.0000
872 PRODUCTIVE COUGH 2 0.0000
873 BLOOD PRESSURE FLUCTUATION 1 0.0000
874 TOXICITY TO VARIOUS AGENTS 7 0.0000
875 LOCALISED INFECTION 1 0.0000
876 CEREBROVASCULAR ACCIDENT 7 0.0000
877 CEREBRAL INFARCTION 1 0.0000
878 VISUAL IMPAIRMENT 5 0.0000
879 AGEUSIA 1 0.0000
880 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
881 ABDOMINAL PAIN LOWER 1 0.0000
882 FLUID RETENTION 2 0.0000
883 HYPOPHAGIA 1 0.0000
884 HEPATITIS 1 0.0000
885 HOSPITALISATION 6 0.0000
886 DRUG RESISTANCE 1 0.0000
887 EXPOSURE VIA SKIN CONTACT 1 0.0000
888 DEATH 33 0.0000
889 HAEMORRHAGE 4 0.0000
890 GASTRITIS 1 0.0000
891 NASOPHARYNGITIS 7 0.0000
892 PANCREATITIS 2 0.0000
893 BRADYCARDIA 2 0.0000
894 BLOOD BILIRUBIN INCREASED 1 0.0000
895 OEDEMA 2 0.0000
896 NEUTROPENIA 5 0.0000
897 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
898 ANAPHYLACTIC REACTION 2 0.0000
899 MENTAL STATUS CHANGES 1 0.0000
900 INFLUENZA 4 0.0000
901 OXYGEN SATURATION DECREASED 2 0.0000
902 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
903 MYOCARDIAL INFARCTION 6 0.0000
904 PRODUCT STORAGE ERROR 3 0.0000
905 MUSCULOSKELETAL STIFFNESS 3 0.0000
906 ACUTE MYOCARDIAL INFARCTION 1 0.0000
907 HEPATIC FAILURE 1 0.0000
908 CORONARY ARTERY DISEASE 1 0.0000
909 INJECTION SITE RASH 1 0.0000
910 ADVERSE EVENT 3 0.0000
911 OROPHARYNGEAL PAIN 3 0.0000
912 WEIGHT DECREASED 9 0.0000
913 SWELLING 3 0.0000
914 OFF LABEL USE 28 0.0000
915 DRUG-INDUCED LIVER INJURY 1 0.0000
916 NEUROPATHY PERIPHERAL 3 0.0000
917 HYPOTHYROIDISM 1 0.0000
918 METABOLIC ACIDOSIS 1 0.0000
919 MOVEMENT DISORDER 1 0.0000
920 INFUSION RELATED REACTION 2 0.0000
921 NEOPLASM MALIGNANT 2 0.0000
922 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
923 HAEMATURIA 1 0.0000
924 INJECTION SITE REACTION 2 0.0000
925 INJURY 2 0.0000
926 HYPOXIA 1 0.0000
927 INFECTION 4 0.0000
928 C-REACTIVE PROTEIN INCREASED 1 0.0000
929 HYPERGLYCAEMIA 1 0.0000
930 COLITIS 1 0.0000
931 DIABETES MELLITUS 2 0.0000
932 INJECTION SITE SWELLING 2 0.0000
933 PERIPHERAL SWELLING 4 0.0000
934 ARTHRITIS 2 0.0000
935 INJECTION SITE BRUISING 2 0.0000
936 PROSTATE CANCER 2 0.0000
937 BLINDNESS 1 0.0000
938 LUNG NEOPLASM MALIGNANT 1 0.0000
939 CARDIAC ARREST 2 0.0000
940 INJECTION SITE ERYTHEMA 3 0.0000
941 CARDIO-RESPIRATORY ARREST 1 0.0000
942 SKIN EXFOLIATION 2 0.0000
943 HYPOACUSIS 1 0.0000
944 COLITIS ULCERATIVE 1 0.0000
945 DEVICE ISSUE 2 0.0000
946 BLOOD CHOLESTEROL INCREASED 1 0.0000
947 DISEASE RECURRENCE 1 0.0000
948 BLOOD GLUCOSE DECREASED 1 0.0000
949 CONTUSION 2 0.0000
950 INTERSTITIAL LUNG DISEASE 1 0.0000
951 HYPOGLYCAEMIA 1 0.0000
952 LUNG DISORDER 1 0.0000
953 HAEMOGLOBIN DECREASED 2 0.0000
954 INFLAMMATION 1 0.0000
955 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
956 ECZEMA 1 0.0000
957 DERMATITIS ATOPIC 1 0.0000
958 DRUG DEPENDENCE 3 0.0000
959 DEPENDENCE 1 0.0000
960 DEEP VEIN THROMBOSIS 1 0.0000
961 PSORIASIS 2 0.0000
962 RENAL FAILURE 2 0.0000
963 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
964 DEVICE MALFUNCTION 1 0.0000
965 BRONCHITIS 1 0.0000
966 CHRONIC KIDNEY DISEASE 1 0.0000
967 INCORRECT DOSE ADMINISTERED 3 0.0000
968 CARDIAC FAILURE 1 0.0000
969 CARDIAC FAILURE CONGESTIVE 1 0.0000
970 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
971 DRUG WITHDRAWAL SYNDROME 1 0.0000
972 GASTROINTESTINAL DISORDER 1 0.0000
973 ADVERSE DRUG REACTION 1 0.0000
974 BREAST CANCER 1 0.0000
975 BLOOD GLUCOSE INCREASED 2 0.0000
976 ANAEMIA 2 0.0000
977 FLUSHING 1 0.0000
978 INJECTION SITE PAIN 3 0.0000
979 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
980 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
981 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000